Mediators of Inflammation

Intravitreal Inflammation: From Benchside to Bedside


Publishing date
02 Nov 2012
Status
Published
Submission deadline
15 Jun 2012

Lead Editor

1Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia


Intravitreal Inflammation: From Benchside to Bedside

Description

Inflammation plays a major role in the formation and in the progression of several chorioretinal diseases. A variety of factors are then released into the vitreous cavity, which can be more easily accessed for diagnostic purposes. Advances in the analysis of vitreous humour samples have highlighted new biological mechanisms of long-known diseases, providing a new perspective for therapeutic strategies. The analysis of vitreous samples is also instrumental for the differential diagnosis of inflammatory versus infective or neoplastic diseases of the eye. We particularly take an interest in manuscripts that report relevance of vitreous samples analyses for improved diagnosis, prognosis, or monitoring of therapy. Potential topics include, but are not limited to:

  • Proteomic analyses of the vitreous humour
  • Profile of lipid and soluble factor in diabetic retinopathy
  • Vitreous mediators in retinal hypoxic disease
  • Mechanism of inflammation in age-related macular degeneration
  • Mediators of inflammation in proliferative vitreoretinal disease
  • Vitreous diagnosis in neoplastic disease
  • Vitreous tap analysis in the management of uveitis
  • Intravitreal devices in treatment of vitreous inflammation
  • Systemic treatment of vitreous inflammation

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/mi/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2013
  • - Article ID 758035
  • - Editorial

Intravitreal Inflammation: From Benchside to Bedside

Mario R. Romano | John Christoforidis | Ahmed M. Abu El-Asrar
  • Special Issue
  • - Volume 2013
  • - Article ID 935301
  • - Review Article

Vitreous Mediators in Retinal Hypoxic Diseases

Roberto dell'Omo | Francesco Semeraro | ... | Ciro Costagliola
  • Special Issue
  • - Volume 2012
  • - Article ID 546786
  • - Review Article

Mechanism of Inflammation in Age-Related Macular Degeneration

Francesco Parmeggiani | Mario R. Romano | ... | Adolfo Sebastiani
  • Special Issue
  • - Volume 2012
  • - Article ID 863418
  • - Review Article

Vitreous Analysis in the Management of Uveitis

Erika M. Damato | Martina Angi | ... | Ciro Costagliola
  • Special Issue
  • - Volume 2012
  • - Article ID 697489
  • - Research Article

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy

Ahmed M. Abu El-Asrar | Mohd Imtiaz Nawaz | ... | Ghulam Mohammad
  • Special Issue
  • - Volume 2012
  • - Article ID 493043
  • - Clinical Study

Osteopontin and Other Regulators of Angiogenesis and Fibrogenesis in the Vitreous from Patients with Proliferative Vitreoretinal Disorders

Ahmed M. Abu El-Asrar | Mohd Imtiaz Nawaz | ... | Karel Geboes
  • Special Issue
  • - Volume 2012
  • - Article ID 930704
  • - Review Article

Vitreous Diagnosis in Neoplastic Diseases

Mónica Asencio-Duran | José Luis Vallejo-Garcia | ... | Mario R. Romano
  • Special Issue
  • - Volume 2012
  • - Article ID 815937
  • - Review Article

Mechanisms of Inflammation in Proliferative Vitreoretinopathy: From Bench to Bedside

Stavros N. Moysidis | Aristomenis Thanos | Demetrios G. Vavvas
  • Special Issue
  • - Volume 2012
  • - Article ID 872978
  • - Review Article

Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy

Olga Simó-Servat | Cristina Hernández | Rafael Simó
  • Special Issue
  • - Volume 2012
  • - Article ID 629452
  • - Review Article

Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy

Daniel Gologorsky | Aristomenis Thanos | Demetrios Vavvas
Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.